A Pilot Mitochondrial Genome-Wide Association on Migraine Among Saudi Arabians.
CYTB gene
Saudi Arabia
migraine
mitochondrial DNA
mtDNA variations
Journal
International journal of general medicine
ISSN: 1178-7074
Titre abrégé: Int J Gen Med
Pays: New Zealand
ID NLM: 101515487
Informations de publication
Date de publication:
2022
2022
Historique:
received:
21
04
2022
accepted:
06
07
2022
entrez:
29
7
2022
pubmed:
30
7
2022
medline:
30
7
2022
Statut:
epublish
Résumé
Mitochondrial DNA (mtDNA) mutations have been reported in multiple neurological diseases and helped to explain the pathophysiology of these diseases. Similarly, variations in mtDNA might exist in migraine and can explain the effect of low ATP production in the neurons on the initiation of migraine attack. Therefore, in the current study we aim to explore the association of mtDNA mutations on migraine in the Saudi population. Over 1950 young Saudi female students were screened for migraine, among that a total of 103 satisfied the ICHD-3 criteria. However, 20 migraine cases confirmed in the neurology clinic and gave consent to participate in the study. Another 20 age-matched healthy controls were also recruited. Mitochondrial sequence variations were filtered from exome sequencing using NCBI GenBank Reference Sequence: NC_012920.1 and analysed using MITOMAP. Genes with significant single nucleotide polymorphisms (SNPs) were investigated by the gene functional classification tool DAVID and functional enrichment analysis of protein-protein interaction networks through STRING 11.5 for the most significant associated genes. Genome wide analysis of the mitochondrial sequence variations between the patients with migraine and control revealed the association of 30 SNPs ( This is the first study to demonstrate the association of mtDNA variations with migraine in the Saudi population. The current findings will help to highlight the significance of mtDNA mutations to migraine pathophysiology and will serve as a reference data for larger national and international studies.
Sections du résumé
Background
UNASSIGNED
Mitochondrial DNA (mtDNA) mutations have been reported in multiple neurological diseases and helped to explain the pathophysiology of these diseases. Similarly, variations in mtDNA might exist in migraine and can explain the effect of low ATP production in the neurons on the initiation of migraine attack. Therefore, in the current study we aim to explore the association of mtDNA mutations on migraine in the Saudi population.
Subjects and Methods
UNASSIGNED
Over 1950 young Saudi female students were screened for migraine, among that a total of 103 satisfied the ICHD-3 criteria. However, 20 migraine cases confirmed in the neurology clinic and gave consent to participate in the study. Another 20 age-matched healthy controls were also recruited. Mitochondrial sequence variations were filtered from exome sequencing using NCBI GenBank Reference Sequence: NC_012920.1 and analysed using MITOMAP. Genes with significant single nucleotide polymorphisms (SNPs) were investigated by the gene functional classification tool DAVID and functional enrichment analysis of protein-protein interaction networks through STRING 11.5 for the most significant associated genes.
Results
UNASSIGNED
Genome wide analysis of the mitochondrial sequence variations between the patients with migraine and control revealed the association of 30 SNPs (
Conclusion
UNASSIGNED
This is the first study to demonstrate the association of mtDNA variations with migraine in the Saudi population. The current findings will help to highlight the significance of mtDNA mutations to migraine pathophysiology and will serve as a reference data for larger national and international studies.
Identifiants
pubmed: 35903646
doi: 10.2147/IJGM.S371707
pii: 371707
pmc: PMC9316482
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6249-6258Informations de copyright
© 2022 Al Asoom et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interests in this work.
Références
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Cephalalgia. 2009 Jul;29(7):719-28
pubmed: 19220304
Eur J Neurol. 2016 Jan;23(1):175-81
pubmed: 26435168
J Biol Chem. 2020 Dec 25;295(52):18406-18425
pubmed: 33127643
Int J Gen Med. 2020 May 27;13:235-241
pubmed: 32547165
Curr Opin Neurol. 2012 Jun;25(3):252-62
pubmed: 22487570
BMC Neurol. 2011 Jul 12;11:85
pubmed: 21749722
Cephalalgia. 2020 May;40(6):625-634
pubmed: 32056457
Nucleic Acids Res. 2017 Jan 4;45(D1):D362-D368
pubmed: 27924014
J Neurol Sci. 2020 Aug 15;415:116870
pubmed: 32428756
J Pathol. 2012 Jan;226(2):274-86
pubmed: 21989606
Cephalalgia. 2006 Apr;26(4):361-72
pubmed: 16556237
Cells. 2019 Jan 29;8(2):
pubmed: 30700008
Nucleic Acids Res. 2020 Nov 18;48(20):11244-11258
pubmed: 33021629
Nature. 1988 Feb 25;331(6158):717-9
pubmed: 2830540
Nucleic Acids Res. 2019 Jul 2;47(W1):W59-W64
pubmed: 30949694
Neuropsychiatr Dis Treat. 2021 Apr 22;17:1183-1194
pubmed: 33911866
Biochim Biophys Acta. 2013 Nov-Dec;1827(11-12):1346-61
pubmed: 23220121
Hum Genet. 2018 Mar;137(3):203-213
pubmed: 29423652
J Med Genet. 2001 Jun;38(6):400-5
pubmed: 11424923
Hum Mol Genet. 2015 Jun 1;24(11):3248-56
pubmed: 25736212
Semin Pediatr Neurol. 2013 Sep;20(3):188-93
pubmed: 24331360
Nucleic Acids Res. 2007 Jan;35(Database issue):D823-8
pubmed: 17178747
Cells. 2019 Apr 25;8(4):
pubmed: 31027297
Mol Biol Rep. 2013 Dec;40(12):6837-41
pubmed: 24158608
Mol Genet Genomics. 2012 Dec;287(11-12):837-44
pubmed: 23052833
J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):936-8
pubmed: 23355809